Woodward Inc

The Bear enters the Blackout Period in the Cruelest Month of the Year Insider Buying Week 9-2-22

by

Curious how well insiders are doing with their buys? Scroll through the blog posts and see for yourself A few insiders stepped up and bought shares in their companies stock. We try to figure out why when just about anything you buy goes down.  With war raging in Europe, Russia weaponizing energy, the Fed on an aggressive tightening path, and the uncertainty of upcoming midterm elections, what’s there not to like? U.S. equities fell again on Friday, marking six continuous days of sell-offs, aided by the fears that the Federal Reserve would keep aggressively hiking interest rates to fight inflation, … Read more

Insider Buying Week 8-26-22 Jerome Powell Debuts at Jackson Hole as “Chucky “

by

Curious how well insiders are doing with their buys? Scroll through the significant buys of the last year. Friday was a blood bath. The Dow dropped 1000 points. Jerome Powell played Chucky, the criminally insane doll that came to life.  With stunning, chameleon-like performance, he morphed into Paul Volcker, warning the investment community about the pernicious destructive nature of inflation.  Volcker is the Fed Chairman that was famous for crushing the inflation of the 1970s by running interest rates into the high teen percentage points. I personally think it was the most boneheaded policy I’ve lived through. the economic equivalent … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more